Cureconnect.org

As many as 95 percent of experimental medicines and treatments fail during research or testing phases, and, according to recent research, the cost of developing a single new drug can be as high as $5bn. Over the years, the development of new drugs has...

By Jason Napodano, CFA We recently sat down with Amarantus Bioscience Holdings (AMBS) CEO, Gerald Commissiong. The meeting confirmed our belief that Amarantus is in the midst of a fundamental turnaround and has significant growth potential over the...

The Phyllis & Jerome Lyle Rappaport Foundation has helped to pave the way to improving – even revolutionizing – the treatment of neurologic and mental illness. It consistently drives medical innovations and healthcare advances that promise to usher...

Once doomed to a life of darkness, dozens of people stricken by retinal diseases are rediscovering a world of light as scientists push ahead on cures for blindness. (AFP/Karen Bleier) Paris – Once doomed to a life of darkness, dozens of people stricken...

Reading someone’s facial expressions; looking at the night sky, or browsing the internet – these are mundane tasks that hardly require our attention. But not everyone can call them routine; for the 285 million people worldwide who are visually impaired...